Prescription Opioid Formulation to Deter Extraction, Injection, Insufflation, and Smoking
用于阻止提取、注射、吹入和吸烟的处方阿片制剂
基本信息
- 批准号:9893842
- 负责人:
- 金额:$ 19.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-03-15 至 2023-02-28
- 项目状态:已结题
- 来源:
- 关键词:Absence of pain sensationAerosolsAffectAnalgesicsBile AcidsBloodCause of DeathCessation of lifeChemicalsClinicalCocaineDangerousnessDevelopmentDiffusionDoseDrug PrescriptionsEffectivenessEncapsulatedEpidemicEvaluationFormulationFutureGenderGuidelinesHealthHealth Care CostsHeroinHydrogelsIndividualIngestionInjectionsInsufflationLabelLeadLiverMaximum Tolerated DoseMechanicsMedicalMethodsMucous body substanceOpioidOverdosePain managementPatientsPersonsPharmaceutical PreparationsPhysiologicalPlasmaPolymersPolysaccharidesPowder dose formProceduresPropertyRaceResistanceResourcesRiskRouteSchemeSerumSmokeSmokingSocioeconomic StatusSolventsSurfaceSystemTabletsTemperatureTestingTimeUnited StatesUpdateWateraddictionassaultbasecapsuledesigngut microbiomeinnovationintravenous injectionlaxativemeltingnanoparticlenanoparticle drugnovelopioid abuseoverdose deathpain reliefparticlephysical propertypillprescription drug abuseprescription opioidpreventresponsevaporizationweb site
项目摘要
PROJECT SUMMARY/ABSTRACT:
In the United States, there are currently more prescriptions for opioids than there are people. The number of
deaths caused by drug overdoses continues to increase, with more than 60% involving prescription opioids. As
a result, an estimated 42,000 people will be lost to the drug epidemic this year alone. What often begins as a
temporary relief of pain can transition into an addiction that requires increased doses or a more efficient means
of getting the drug into the person's system. Thus, patients have developed methods for processing the
prescription pills to prepare them for alternative routes of administration such as injection, insufflation, or
smoking. However, these alternative routes of administration can cause unsafe blood serum levels of the drug
and lead to an overdose. Therefore, we propose to develop a novel abuse deterrent formulation (ADF) that will
be uniquely designed to prevent abuse of the prescription pill. The proposal will be performed in 2 aims. The
first aim will focus on the development of the ADF formulation with design aspects specifically focused on
abuse through insufflation, smoking, injection and taking multiple pills. In Aim 2 we will focus on validating the
design by putting the pill through a rigorous test following the procedures outlined by the FDA Abuse-Deterrent
Opioids-Evaluation and Labeling guidelines. Our proposed studies will result in the development of a novel
ADF formulation that will be resistant to a wide range of tampering, resulting in a safer formulation and pill
design.
项目总结/摘要:
在美国,目前阿片类药物的处方比人还多。的数量
药物过量造成的死亡继续增加,60%以上涉及处方类阿片。作为
因此,仅今年一年,估计就有42 000人因毒品流行而丧生。一开始,
暂时缓解疼痛可能会转变为需要增加剂量或更有效手段的成瘾
让药物进入人体系统因此,患者已经开发了用于处理
处方药,以准备用于替代给药途径,如注射,吹入,或
smoking.然而,这些替代给药途径可能导致药物的不安全血清水平
导致吸毒过量因此,我们建议开发一种新的抗滥用配方,
设计独特,以防止滥用处方药。该提案将在2个目标中执行。的
第一个目标将侧重于ADF公式的开发,设计方面特别侧重于
通过吹气、吸烟、注射和服用多种药丸滥用。在目标2中,我们将重点验证
根据FDA滥用预防计划概述的程序,
阿片类药物-评价和标签指南。我们的研究计划将导致一部小说的发展
ADF配方,可抵抗广泛的篡改,从而产生更安全的配方和药丸
设计
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
PLA-PCL microsphere formulation to deter abuse of prescription opioids by smoking.
PLA-PCL 微球制剂可防止通过吸烟滥用处方阿片类药物。
- DOI:10.1016/j.ijpharm.2022.122151
- 发表时间:2022
- 期刊:
- 影响因子:5.8
- 作者:Vasiukhina,Anastasiia;Gad,SheryhanF;Wellington,ElyssiaN;Wilmes,DanielleM;Yeo,Yoon;Solorio,Luis
- 通讯作者:Solorio,Luis
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Luis Solorio其他文献
Luis Solorio的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Luis Solorio', 18)}}的其他基金
相似海外基金
AEROSOLS - AIR QUALITY AND HEALTH IMPACT OF PRIMARY SEMI-VOLATILE AND SECONDARY PARTICLES AND THEIR ABATEMENT
气溶胶 - 一次半挥发性颗粒和二次颗粒对空气质量和健康的影响及其消除
- 批准号:
10092043 - 财政年份:2024
- 资助金额:
$ 19.38万 - 项目类别:
EU-Funded
Molecular-level Understanding Of Atmospheric Aerosols (MUOAA 2024); Corsica, France; April 1-5, 2024
对大气气溶胶的分子水平理解(MUOAA 2024);
- 批准号:
2332007 - 财政年份:2024
- 资助金额:
$ 19.38万 - 项目类别:
Standard Grant
TWISTA (The Wide-ranging Impacts of STratospheric smoke Aerosols)
TWISTA(平流层烟雾气溶胶的广泛影响)
- 批准号:
NE/Y000021/1 - 财政年份:2024
- 资助金额:
$ 19.38万 - 项目类别:
Research Grant
TWISTA (The Wide-ranging Impacts of STratospheric smoke Aerosols)
TWISTA(平流层烟雾气溶胶的广泛影响)
- 批准号:
NE/Y000358/1 - 财政年份:2024
- 资助金额:
$ 19.38万 - 项目类别:
Research Grant
Southern Ocean aerosols: sources, sinks and impact on cloud properties
南大洋气溶胶:来源、汇以及对云特性的影响
- 批准号:
DP240100389 - 财政年份:2024
- 资助金额:
$ 19.38万 - 项目类别:
Discovery Projects
INvestigating Home water and Aerosols' Links to opportunistic pathogen Exposure (INHALE): do consumer decisions impact pathogen exposure and virulence?
调查家庭用水和气溶胶与机会性病原体暴露(吸入)的联系:消费者的决定是否会影响病原体暴露和毒力?
- 批准号:
2326096 - 财政年份:2023
- 资助金额:
$ 19.38万 - 项目类别:
Standard Grant
An AI-driven clinical washbasin unit that automatically disinfects pathogens, reduces aerosols and decreases healthcare-acquired infections by 70%
%20人工智能驱动%20临床%20洗脸盆%20单位%20%20自动%20消毒%20病原体,%20减少%20气溶胶%20和%20减少%20医疗保健获得性%20感染%20by%2070%
- 批准号:
83001507 - 财政年份:2023
- 资助金额:
$ 19.38万 - 项目类别:
Innovation Loans
Cloudbusting with JWST: characterising aerosols, aurorae and chemistry in substellar atmospheresto the water cloud regime
使用 JWST 进行云消除:描述水云状态下恒星大气中的气溶胶、极光和化学成分
- 批准号:
ST/X001091/1 - 财政年份:2023
- 资助金额:
$ 19.38万 - 项目类别:
Research Grant
Bioactivated Aerosols for Combustion Product Capture
用于燃烧产物捕获的生物活性气溶胶
- 批准号:
10080253 - 财政年份:2023
- 资助金额:
$ 19.38万 - 项目类别:
Small Business Research Initiative